Your browser doesn't support javascript.
loading
Targeting syndecan-1: new opportunities in cancer therapy.
Yang, Zecheng; Chen, Shuaitong; Ying, Haoqiang; Yao, Wantong.
Affiliation
  • Yang Z; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen S; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ying H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yao W; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Physiol Cell Physiol ; 323(1): C29-C45, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35584326

Full text: 1 Database: MEDLINE Main subject: Syndecan-1 / Neoplasms Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Syndecan-1 / Neoplasms Limits: Humans Language: En Year: 2022 Type: Article